Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Selegiline for Smoking Cessation

NCT00129311 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00129311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00129311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Selegiline for Smoking Cessation
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
December 31, 2012
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use cessation